MENU
INDP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Indaptus Therapeutics (INDP) Ownership - Who owns Indaptus Therapeutics?
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more
Profile
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.01M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
59.51K
Revenue
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INDP
Capitalization
8.02M
P/E Ratio
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
59.5K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
2.8M
P/B Ratio
2.86
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
160K
Current Ratio
1.90
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
682K
Shares Outstanding - Current
1.12M
Total Liabilities
2.61M
Total Volume MTD
N/A
Value
1
Gain YTD
-69.604
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. INDP showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3 Columbus Circle
Phone
+1 646 427-2727
Employees
7
Web
https://www.indaptusrx.com